These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 7183249)

  • 1. [Modification of the triphasic mortality curve of d-amphetamine].
    Garrido García J; Pérez Naranjo J; Martínez Roldán C
    Arch Farmacol Toxicol; 1982 Dec; 8(3):185-8. PubMed ID: 7183249
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparative study of the central effects of M-14012-A and SKF-525-A in rodents].
    Garrido J; Pérez Naranjo J; Martínez Roldán C
    Arch Farmacol Toxicol; 1983 Aug; 9(2):191-202. PubMed ID: 6660935
    [No Abstract]   [Full Text] [Related]  

  • 3. The triphasic amphetamine lethal dose curve in mice and its possible relationship to drug metabolism.
    James RC; Franklin MR
    Toxicol Appl Pharmacol; 1978 Apr; 44(1):63-73. PubMed ID: 675694
    [No Abstract]   [Full Text] [Related]  

  • 4. Tissue concentrations and the mortality of d-amphetamine in mice: changes associated with the use of diethylaminoethyl 2,2-diphenylvalerate.HCl1.
    James RC; Franklin MR
    Toxicol Appl Pharmacol; 1978 Apr; 44(1):75-80. PubMed ID: 675695
    [No Abstract]   [Full Text] [Related]  

  • 5. Triphasic dose-lethality relationships for amphetamine and certain ring-substituted amphetamines in isolated or aggregated mice.
    Davis WM; Waters IW; Hatoum HT; Buelke JL; Braude MC
    Res Commun Chem Pathol Pharmacol; 1977 Aug; 17(4):575-82. PubMed ID: 578333
    [No Abstract]   [Full Text] [Related]  

  • 6. Toxic interactions of d-amphetamine and tricyclic antidepressants in mice.
    Sokol GH; Maickel RP
    Res Commun Chem Pathol Pharmacol; 1972 May; 3(3):513-21. PubMed ID: 5034512
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of N-(4-picolyl)-3,5 dimethylbenzamide (M-14012-4) on stereotyped behavior induced by apomorphine and amphetamine in the rat and mouse].
    Casais PL; Chermat R; Cuenca E; Simón P
    Arch Farmacol Toxicol; 1981 Apr; 7(1):65-72. PubMed ID: 7198897
    [No Abstract]   [Full Text] [Related]  

  • 8. Hyperthermia in d-amphetamine toxicity in aggregated mice of different strains.
    Craig AL; Kupferberg HJ
    J Pharmacol Exp Ther; 1972 Mar; 180(3):616-24. PubMed ID: 5012784
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of co-administration of bupropion and nicotine or D-amphetamine on the elevated plus maze test in mice.
    Biala G; Kruk M
    J Pharm Pharmacol; 2009 Apr; 61(4):493-502. PubMed ID: 19298697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological modification of shock potentiated amphetamine lethality.
    Wilson MC
    Eur J Pharmacol; 1977 Aug; 44(4):365-74. PubMed ID: 891612
    [No Abstract]   [Full Text] [Related]  

  • 11. Interactions between chlorpromazine and some of its metabolites.
    Shavit S; Kutz I; Korczyn AD; Gitter S
    Commun Psychopharmacol; 1980; 4(6):495-500. PubMed ID: 7197607
    [No Abstract]   [Full Text] [Related]  

  • 12. Paradoxical effects of d-amphetamine upon seizure susceptibility in 2 selectively bred lines of mice.
    Greer CA; Alpern HP
    Dev Psychobiol; 1980 Jan; 13(1):7-15. PubMed ID: 7353724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age, confinement and aggregation as factors in amphetamine group toxicity in mice.
    Chernov HI; Furness P; Partyka D; Plummer AJ
    J Pharmacol Exp Ther; 1966 Nov; 154(2):346-9. PubMed ID: 5922995
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of physical exercise on markers of acute cardiotoxicity induced by d-amphetamine in an animal model.
    Ferreira MT; Ferreira R; Carvalho F; Duarte JA
    Rev Port Cardiol; 2006 Nov; 25(11):983-96. PubMed ID: 17274456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium channel antagonists suppress cross-tolerance to the anxiogenic effects of D-amphetamine and nicotine in the mouse elevated plus maze test.
    Biala G; Kruk M
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):54-61. PubMed ID: 17761379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletion of Melanin-Concentrating Hormone Receptor-1 gene accentuates D-amphetamine-induced psychomotor activation but neither the subsequent development of sensitization nor the expression of conditioned activity in mice.
    Tyhon A; Lakaye B; Grisar T; Tirelli E
    Pharmacol Biochem Behav; 2008 Feb; 88(4):446-55. PubMed ID: 17996928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. alpha(2A)-Adrenoceptors regulate d-amphetamine-induced hyperactivity and behavioural sensitization in mice.
    Juhila J; Honkanen A; Sallinen J; Haapalinna A; Korpi ER; Scheinin M
    Eur J Pharmacol; 2005 Jul; 517(1-2):74-83. PubMed ID: 15978573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Semax potentiates effects of D-amphetamine on the level of extracellular dopamine in the Sprague-Dawley rat striatum and on the locomotor activity of C57BL/6 mice].
    Eremin KO; Saransaari P; Oja S; Raevskiĭ KS
    Eksp Klin Farmakol; 2004; 67(2):8-11. PubMed ID: 15188751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modification of the behavioral effects of (+/-)BAY k 8644, cocaine and d-amphetamine by L-type calcium channel blockers in squirrel monkeys.
    Rosenzweig-Lipson S; Barrett JE
    J Pharmacol Exp Ther; 1995 Aug; 274(2):842-51. PubMed ID: 7543574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of potent and orally active 3-alkoxy-5-phenoxy-N-thiazolyl benzamides as novel allosteric glucokinase activators.
    Iino T; Tsukahara D; Kamata K; Sasaki K; Ohyama S; Hosaka H; Hasegawa T; Chiba M; Nagata Y; Eiki J; Nishimura T
    Bioorg Med Chem; 2009 Apr; 17(7):2733-43. PubMed ID: 19282189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.